STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our newsletters here:
加入 July 2015
4.7K 正在關注 165.1K 粉絲
AstraZeneca and Ionis Pharmaceuticals detailed the surprise failure of their silencer in an ATTR-CM trial.
Investigators think the high proportion of patients already on a stabilizer drug at the start of the trial caused the miss. More details here:
顯示更多
